(Q51242700)

English

Individualized dosimetry-based activity reduction of ⁹⁰Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapy.

scientific article published on 26 March 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668274%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Individualized dosimetry-based activity reduction of ⁹⁰Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668274%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668274%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Christophe Deroose

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668274%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

author name string

Sofie Van Binnebeek

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668274%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Kristof Baete

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668274%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Bert Vanbilloen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668274%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Christelle Terwinghe

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668274%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Michel Koole

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668274%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Felix M Mottaghy

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668274%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Paul M Clement

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668274%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Luc Mortelmans

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668274%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Karin Haustermans

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668274%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Eric Van Cutsem

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668274%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Alfons Verbruggen

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668274%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Chris Verslype

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668274%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

publication date

26 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668274%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668274%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

41

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668274%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668274%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1141-1157

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24668274%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

https://scigraph.springernature.com/pub.10.1007/s00259-013-2670-x

0 references

Gastroenteropancreatic neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

90Y-edotreotide for metastatic carcinoid refractory to octreotide

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

Peptide receptor radionuclide therapy with ¹⁷⁷Lu-DOTATATE: the IEO phase I-II study

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)--a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

Cerebral deafferentiation in operated gliomas as a predictor for malignancy?

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

End-stage renal disease after treatment with 90Y-DOTATOC.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

Between the Scylla and Charybdis of peptide radionuclide therapy: hitting the tumor and saving the kidney

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

A new cause of renal thrombotic microangiopathy: yttrium 90-DOTATOC internal radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours: comparison of (86)Y-DOTATOC and (111)In-DTPA-octreotide

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

Extension of the biological effective dose to the MIRD schema and possible implications in radionuclide therapy dosimetry

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

MIRD pamphlet No. 20: the effect of model assumptions on kidney dosimetry and response--implications for radionuclide therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

Is the Renal Dosimetry for [90Y-DOTA0, Tyr3]Octreotide Accurate Enough to Predict Thresholds for Individual Patients?

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-TOC versus [90Y-DOTA]-TOC in neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA(0),Tyr3]octreotate

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

Quantitative analysis of 90Y Bremsstrahlung SPECT-CT images for application to 3D patient-specific dosimetry.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

90Y PET-based dosimetry after selective internal radiotherapy treatments.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

4-Step renal dosimetry dependent on cortex geometry applied to 90Y peptide receptor radiotherapy: evaluation using a fillable kidney phantom imaged by 90Y PET.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2670-X

21 January 2018

New advances in peptide receptor radionuclide therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24668274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A formula to estimate the approximate surface area if height and weight be known. 1916.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24668274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24668274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate

1 reference

https://pubmed.ncbi.nlm.nih.gov/24668274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship

1 reference

https://pubmed.ncbi.nlm.nih.gov/24668274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Yttrium-90-labelled somatostatin-analogue for cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/24668274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered biodistribution of somatostatin analogues after first cycle of Peptide receptor radionuclide therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24668274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine

1 reference

https://pubmed.ncbi.nlm.nih.gov/24668274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MIRD Pamphlet No 19: absorbed fractions and radionuclide S values for six age-dependent multiregion models of the kidney

1 reference

https://pubmed.ncbi.nlm.nih.gov/24668274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dosimetry in Peptide radionuclide receptor therapy: a review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24668274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation nephropathy after radiotherapy in metastatic medullary thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24668274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolerance of normal tissue to therapeutic irradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24668274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Yttrium-90 DOTATOC: first clinical results

1 reference

https://pubmed.ncbi.nlm.nih.gov/24668274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new model of proliferative response to fractionated irradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24668274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24668274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significant impact of transient deterioration of renal function on dosimetry in PRRT

1 reference

https://pubmed.ncbi.nlm.nih.gov/24668274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51242700&oldid=1723280294"